Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review. (2021)
Attributed to:
Strategies to reduce the burden of antibiotic resistance in China
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/antibiotics10060745
PubMed Identifier: 34205440
Publication URI: http://europepmc.org/abstract/MED/34205440
Type: Journal Article/Review
Volume: 10
Parent Publication: Antibiotics (Basel, Switzerland)
Issue: 6
ISSN: 2079-6382